U.S. Vaccine Program Now Flush With Cash but Short on Key Details
A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.
from NYT > U.S. > Politics https://ift.tt/xvEMa3F
from NYT > U.S. > Politics https://ift.tt/xvEMa3F
Comments
Post a Comment